Which population is advised to receive the HPV vaccine?

The recommendation for vaccinating all adolescents at ages 11-12 reflects public health guidelines aimed at maximizing the effectiveness of the human papillomavirus (HPV) vaccine. Administering the vaccine around this age allows for optimal immune response, as younger individuals tend to develop a stronger immunity compared to older populations. The vaccine is intended to prevent HPV infections that can lead to various cancers, and vaccinating adolescents helps in establishing immunity before the onset of sexual activity.

Additionally, the HPV vaccine is not limited to one gender, and it is advised for both males and females. This broad approach ensures comprehensive protection across the population, further reducing the transmission of HPV and related health issues.

In contrast, the other choices focus on more restricted groups which do not align with the universal vaccination strategy recommended by health authorities. The policies encourage early vaccination in adolescents rather than limiting it to specific age brackets or groups.